Notice of Intent to Publish a Funding Opportunity Announcement for Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research (U18 – Clinical Trial Not Allowed)

0
138

Opportunity ID: 321318
Opportunity Number: NOT-DA-19-076
Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research (U18 – Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.279
Eligible Applicants: State governments
County governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Oct 04, 2019
Last Updated Date: Oct 04, 2019
Estimated Synopsis Post Date: Oct 30, 2019
Fiscal Year: 2020
Award Ceiling: $150,000
Award Floor:
Estimated Total Program Funding: $150,000
Expected Number of Awards:
Description: The National Institute on Drug Abuse (NIDA) intends to publish a Funding Opportunity Announcement (FOA) to establish 50 new awards for the “Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research” program to provide short-term funding to conduct experiments aiming to expand the range of drug targets and mechanisms for SUD therapies. In addition, the FOA will allow for in-kind access to biomedical product development expertise, business strategy and commercialization support, and assistance in the company/startup formation, as needed. It will be administered as a unique, short-term and nimble funding opportunity to support the confirmatory research in robust drug target validation/invalidation to allow for early decision to either proceed to the next step or stop the project. At this point, only research projects on potential drug/biologic therapeutics, not diagnostics or devices, will be supported. Applications to test new therapeutic ideas (a new mechanism/ target class for SUD or a new SUD indication for a validated mechanism/ target class), especially for cocaine, methamphetamine, or cannabis use disorders are encouraged. For each project funded under this FOA, the NIDA will assemble an NIH expert panel called a Project Development Team (PDT) comprising of Program Official (PO), Science Officer (SO), the PI/PD and appropriate NIH expert consultants. Together, the team will create a credible thesis for how the PI/PD will address an important SUD issue in a transformative way, differentiate from other approaches, and create a path for progressively de-risking that opportunity. The PDT will help the PD/PI establish an overall strategy for the project, including identifying the critical value inflection point to determine what needs to be done in the preceding stage to make the technology attractive to potential partners. The FOA will utilize the U18 funding mechanism, which is a cooperative agreement, a support mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, NIH scientific or program staff will assist, guide, coordinate, or participate in project activities.
Version: 1





Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research (U18 – Clinical Trial Not Allowed)